Illumina to take full ownership of cancer screening company GRAIL in $8bn deal

pharmanewsdaily- September 21, 2020 0

Illumina acquisition of GRAIL : US sequencing company Illumina has agreed to fully acquire California-based cancer screening company GRAIL in a cash and stock deal ... Read More